How to Buy Checkpoint Therapeutics Stock
Checkpoint Therapeutics Inc
Checkpoint Therapeutics, Inc. , clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers.
Checkpoint Therapeutics stock last closed at $1.67, down 1.18% from the previous day, and has decreased 35.02% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. Checkpoint Therapeutics stock is currently +28.46% from its 52-week low of $1.30, and -53.87% from its 52-week high of $3.62.
At the moment, there are 35.69M CKPT shares outstanding. The market capitalization of CKPT is $59.60M. In the past 24 hours, 267,826 CKPT shares were traded.
How to Buy Checkpoint Therapeutics Stock
Not sure how to invest in Checkpoint Therapeutics stock? Here's how.
- Decide where to buy Checkpoint Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Checkpoint Therapeutics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Pick your method of payment and add your information.
- Analyze Checkpoint Therapeutics stock: The Checkpoint Therapeutics ticker symbol is CKPT. Is Checkpoint Therapeutics stock a good investment? Should you buy shares of CKPT? How do CKPT's underlying business fundamentals look? Do top analysts think Checkpoint Therapeutics is a good buy? Why has CKPT's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CKPT is a good stock to buy).
- Make your CKPT purchase: Decide if you will purchase CKPT shares at the current market price or use a limit order to buy CKPT stock at a given price.
- Get the latest news on your investment in CKPT: Create a watchlist to get the latest news on your investment in Checkpoint Therapeutics stock.
Step 1: Decide where to buy Checkpoint Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy CKPT shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can buy CKPT stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have opened your account on one of the most highly reviewed stock apps, you need to deposit funds:
Watch this video walkthrough if you need help transferring money into your new investment account.
Step 4: Analyze Checkpoint Therapeutics stock
Once you have decided on the best place to buy Checkpoint Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you truly comprehend the risk as well as the upside.
Checkpoint Therapeutics Metrics
Fundamentals of CKPT
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CKPT's stock page.
How is CKPT stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge CKPT's fair value.
You can access additional valuation research on CKPT's stock here.
A quick look at CKPT Financials
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the CKPT balance sheet.
Negative Financial Indicators:
- CKPT has $4.93M in cash and short term investments. This is not sufficient to cover its annual cash burn of $47.59M.
- CKPT profit margin has gone down from -32,616.7% to -50,336.9% in the past year.
- CKPT debt to equity ratio of -1.41 is negative.
- There are more short-term liabilities than short-term assets on the CKPT balance sheet.
- Total CKPT debt is still negative.
- CKPT has cash burn of 47590000. It does not have enough cash and short-term investments to cover this.
Is it a good time to buy Checkpoint Therapeutics stock, according to analysts?
Out of 2 Wall Street analysts who research CKPT, the consensus analyst rating on Checkpoint Therapeutics is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Checkpoint Therapeutics stock forecast page.
CKPT Trading Indicators
How are CKPT Revenues/Earnings doing?
Last year, CKPT revenue was $103.00k. During the last five year, CKPT's revenue has grown by -50.61% per year. This was slower than the Biotechnology industry average of 29.02%.
Find out more about CKPT's earnings and revenue performance here.
Who is buying/selling CKPT?
In the past year, executives and large shareholders at CKPT have sold more shares than they have bought.
William Garrett Gray, Chief Financial Officer of CKPT, was the latest CKPT insider to sell. They sold $4,212.45 worth of CKPT shares on Feb 28, 2024.
Get more info about who owns CKPT shares here.
Does CKPT provide a stable income stream?
No, Checkpoint Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about CKPT
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your CKPT purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given price limit, use a limit order.
Hit the Open Trade button and eToro will place your order.
If you need more help with investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in CKPT
Now that you own some shares in CKPT, you'll want to stay up-to-date on your new investment.
Make a watchlist to track the latest developments regarding your CKPT stock.
CKPT Feed
How to Buy Stock in Checkpoint Therapeutics
To reiterate, here are the 6 steps to buy Checkpoint Therapeutics stock:
- Decide where to buy Checkpoint Therapeutics stock
- Open a brokerage account
- Put funds into your investment account
- Analyze Checkpoint Therapeutics stock
- Make your CKPT purchase
- Get the latest news on your investment in CKPT
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Checkpoint Therapeutics, click below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.